A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer - 请求报价

media.product.imagealternatetextformat.details

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer

SZ目录编号:SZ-S010013
CAS 号
NA
分子式
C22H29FN3O9P
分子量
529.5
投资状态
Synthesis on demand

化学名称 :

运输温度 :

HSN编码 :

原产国 :

微笑 :

使用说明:

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer is chemically Isopropyl ((S)-(((2R,3R,4R,5S)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-2-(hydroxymethyl)-4-methyltetrahydrofuran-3-yl)oxy)(phenoxy)phosphoryl)-L-alaninate. Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer is supplied with detailed characterization data compliant with regulatory guideline. Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sofosbuvir.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

应用与法规使用场景

buy high quality Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer

采购 Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer 供应商

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer 制造商

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer 价格

订购 Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer

询问 Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer 成本

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer 供应商

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer 分销商

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer 用于方法验证

Sofosbuvir 对照标准

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer 用于ANDA申报

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer 用于强制降解研究

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer 鉴别标准

Sofosbuvir 3'-O-Phosphoramidate alpha-Isomer 用于DMF申报

ℹ️

免责声明

SynZeal 在本网站上提供的产品信息是根据发布时的现有理解而提供的。客户在实际购买时有责任评估信息的准确性。

SynZeal 将根据产品规格的新发展或新发现更新这些详细信息,恕不另行通知。

,